Involving Patients with Low Risk Chest Pain in Discharge Decisions: A Multicenter Trial Erik P. Hess MD MSc.

Slides:



Advertisements
Similar presentations
GUSTO-IV AMI G lobal U se of S trategies T o Open O ccluded Coronary Arteries in AMI.
Advertisements

Tobias Reichlin, W. Hochholzer, C. Stelzig, K. Laule, M. Potocki, K
ACRIN PA 4005: Multicenter Randomized Controlled Study of a Rapid ‘Rule-out’ Strategy Using CT Coronary Angiogram Versus Traditional Care for Low-Risk.
PCI - A prospective, randomized, double- blind substudy of patients undergoing PCI in the CURE trial.
Keith A A Fox Royal Infirmary & University of Edinburgh CURE and PCI-CURE.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
The Chest Pain Choice Decision Aid: a Randomized Trial ISDM Conference Maastricht, June 2011.
A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes Sai Sadanandan, MD*; Christopher.
Management of Acute Myocardial Infarction Minimal Acceptable vs Optimal Care Hussien H. Rizk, MD Cairo University.
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2009.
Kenneth W. Mahaffey, Zhen Huang, Pierluigi Tricoci, Frans Van de Werf, Harvey D. White, Paul W. Armstrong, Claes Held, Sergio Leonardi, Philip E. Aylward,
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
The potential impact of adherence to a guideline on the utilization of head CT scans in traumatic head injury patients. Frederick K. Korley M.D.
PPAR  activation Clinical evidence. Evolution of clinical evidence supporting PPAR  activation and beyond Surrogate outcomes studies Large.
A 2-hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain Symptoms Using Contemporary Troponins as the Only Bbiomarker (ADAPT) Martin.
Sex-Specific Chest Pain Characteristics in AMI Jay Mansfield, Pgy-3 July 22, 2014 LSU Journal Club Gimenez, M, et. Al. Jama Int Med. 2014;174(2):
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Decision Aids Enhancing the Patient Experience Annie LeBlanc PhD Wiser Choices Program Knowledge and Evaluation Research Unit.
Silent Ischemia STABLE CAD
ARMYDA-4 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study Prospective, multicenter, randomized, double blind trial investigating.
Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease: Results from the.
Jim Hoehns, Pharm.D.. Lancet 2013;382: Albers G et al. Chest. 2001; 119 (suppl): 300S. Ischemic stroke 85% Hemorrhagic stroke 15% Other 5% Cryptogenic.
AA-2-1 Jerome D. Cohen, MD, FACC, FACP Professor of Internal Medicine / Cardiology Director, Preventive Cardiology Programs St. Louis University Health.
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
Safety and Efficacy of Switching from Either UFH or Enoxaparin Plus a GP IIb/IIIa Inhibitor to Bivalirudin Monotherapy in Patients with Non-ST Elevation.
Journal Club Jeffrey P Schaefer, MD April 16, 2007.
Daniel I. Sessler Department of O UTCOMES R ESEARCH Cleveland Clinic on behalf of POISE-2 Investigators PeriOperative ISchemic Evaluation-2 Trial POISE-2POISE-2.
Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.
Virtual ACE Update.
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
بسم الله الرحمن الرحیم.
Insights from the PROMISE Trial Neha J. Pagidipati, MD MPH; Kshipra Hemal; Adrian Coles, PhD; Daniel B. Mark, MD MPH; Rowena J. Dolor, MD MHS; Patricia.
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
Unnecessary Lipid Screening of Inpatient Admissions Dennis Whang 4/2/12 DSR2.
Journal Club Julie Shah, MD Milton S Hershey Medical Center Penn State University.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2013.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
FOURIER Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Evaluation of CT Coronary Angiography (CTCA) and Cardiac Magnetic Resonance (CMR) in patients presenting with Acute Chest Pain (ACP) at A&E Background.
Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results Stephen G. Ellis, MD,
The Prognostic Value of Coronary Artery Calcium in the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) Matthew J.
Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:
. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.
HEART PATHWAY Brian O’Neal, MD
Douglas S. Bell, MD, PhD Leader, UCLA CTSI Informatics Program
Evaluation of Patients with chest pain Admitted under General Medicine; Has clinical judgment being taken over by serial troponins? Dr. Samantha Herath.
Cocaine-Related Chest Pain: The Year After
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
Improving Care Processes for Patients with Possible Acute Coronary Syndrome (ICARE-ACS)
Rural Chest Pain Quality Improvement
First time a CETP inhibitor shows reduction of serious CV events
PCSK9 Inhibitors Post-CVOTs
Quality Improvement Program: Chest Pain Outpatient Testing
Disclosures. Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS.
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
Statins Evaluation in Coronary procedUres and REvascularization
Pediatric Minor Head Injury 2.0
Learning Objectives Current Practices in Ruling Out AMI.
The Time Dependence of Anti-thrombin Initiation in Patients with Non-ST-segment –elevation Acute Coronary Syndrome: Subgroup Analysis form the ACUITY.
Elevated Admission Plasma Glucose Following ACS
Chest Pain Choice Trial design: Patients presenting to the ED with low risk chest pain were randomized to either use of a tailored decision aid or routine.
Presentation transcript:

Involving Patients with Low Risk Chest Pain in Discharge Decisions: A Multicenter Trial Erik P. Hess MD MSc

Background Chest Pain 2 nd most common complaint in US EDs 1.5% ACS missed Stress testing frequently obtained in low risk patients False positive test results, unnecessary procedures,  cost

Evidence synthesis (ACS risk estimation tool) Observations clinical encounter Designers Study team Patients Clinicians Stakeholders Initial prototype Field testing Modified prototype Final Decision Aid Evaluation (trial)

Chest Pain Choice Pilot Trial (n=201) OutcomeChange Patient knowledge ↑ Patient engagement ↑ Placed in EDOU for stress testing ↓ (19%) Stress testing within 30 days ↓ (16%) Provider experience ↑ Outpatient follow-up ↑ Safety ↔ Hess, Kline, Stiell et al. Circulation CQO 2012

Objective Test the effectiveness of Chest Pain Choice in a pragmatic multicenter RCT

Methods

Design Patient level RCT Allocation concealed by password-protected, web-based randomization scheme Dynamic randomization 1:1 ratio

Eligibility criteria Inclusion Adults with chest pain considered for EDOU admission for stress testing or coronary CTA Exclusion Ischemic ECG Elevated troponin Known CAD Cocaine use within 72 hours Unable to provide informed consent or use DA

Outcome measures Decision quality Patient knowledge** Degree of patient participation (OPTION scale) Acceptability CV endpoints Safety: 30-day MACE Resource use Admitted to EDOU for stress testing or coronary CT 30-day rate of stress testing/coronary CT

Results

Baseline characteristics VariableControl (n=451) Intervention (n=447) P-value Mean age Female58% HTN55% Dislipidemia69% Family history of premature CAD 59% Mean PTP of ACS 3.8%

Knowledge and Engagement Variable Control (n=451) Intervention (n=447) P-value Knowledge [Mean (SD)] 3.56 (1.50) 4.23 (1.54) <0.001 Engagement (Option scale) 8 18 <0.001

Decision aid acceptability (patient) Control Intervention % P=0.01 P=0.004

Decision aid acceptability (clinician) Control Intervention % P<0.001

Safety Variable Control (n=451) Intervention (n=447) P-value Revascularization4 (1%)7 (2%)0.37 MI1 (0%)4 (1%)1.0 Death0 (0%) 1.0 MACE within 30 days of discharge 0 (0%)1 (0%)1.0

Resource Use Control Intervention % P<0.001 P=0.12

Conclusions Chest Pain Choice Increased patient knowledge and engagement Safely decreased resource use Acceptable to patients and clinicians Next Step: Implementation

E Hess, J Hollander, J Schaeffer, J Kline, C Torres, D Diercks, R Jones, N Shah, J Inselman, J Herrin, A Castaneda-Guarderas, V. Montori Knowledge and Evaluation Research Unit Mayo Clinic MN